XG-102

DRUG3 trials

Sponsors

Xigen SA

Conditions

CataractInflammationPain

Phase 1

Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers

CompletedNCT01570205

Xigen SAInflammation

Start: 2011-07-31End: 2012-02-29Updated: 2012-04-04

Phase 3

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation

CompletedNCT02235272

Xigen SACataract, Inflammation, Pain

Start: 2014-09-30End: 2015-12-31Updated: 2017-01-24

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation and Pain

CompletedNCT02508337

Xigen SACataract, Inflammation, Pain

Start: 2015-07-31End: 2016-03-31Updated: 2017-01-24